{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:31:28Z","timestamp":1786995088256,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.nucmedbio.2007.10.008","type":"journal-article","created":{"date-parts":[[2007,12,21]],"date-time":"2007-12-21T12:56:26Z","timestamp":1198241786000},"page":"227-232","source":"Crossref","is-referenced-by-count":20,"title":["Yttrium-86-labelled human serum albumin microspheres: relation of surface structure with in vivo stability"],"prefix":"10.1016","volume":"35","author":[{"given":"Eik","family":"Schiller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Pietzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Noll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Sterger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Johannsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Wunderlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00fcrgen","family":"Pietzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2007.10.008_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib2","first-page":"419","article-title":"Radioactive microspheres in therapeutics","volume":"59","author":"Sinha","year":"2004","journal-title":"Pharmazie"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/0929867023371454","article-title":"Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumours","volume":"9","author":"Nijsen","year":"2002","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib4","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1148\/rg.25si055515","article-title":"Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications","volume":"25","author":"Murthy","year":"2005","journal-title":"Radiographics"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib5","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/(SICI)1097-0142(19981101)83:9<1894::AID-CNCR4>3.0.CO;2-O","article-title":"Internal radiation therapy for patients with primary or metastatic hepatic cancer","volume":"83","author":"Ho","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/000313480407001103","article-title":"Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma","volume":"70","author":"Liu","year":"2004","journal-title":"Am Surg"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib7","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/01.RVI.0000184594.01661.81","article-title":"Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TherSphere): safety, tumor response, and survival","volume":"16","author":"Salem","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00270-005-0171-4","article-title":"Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization","volume":"29","author":"Sato","year":"2006","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib9","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1023\/A:1013569329846","article-title":"Randomized trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer","volume":"12","author":"Gray","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jso.20141","article-title":"Randomised phase 2 trial of SIR-spheres plus fluoruracil\/leucovorin chemotherapy versus fluoruracil\/leucovorin chemotherapy alone in advanced colorectal cancer","volume":"88","author":"van Hazel","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/cbr.2005.20.200","article-title":"Selective internal radiation therapy with SIR-spheres in patients with nonresectable liver tumors","volume":"20","author":"P\u00f6pperl","year":"2005","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00259-005-1859-z","article-title":"Treatment of hepatocellular carcinoma by means of radiopharmaceuticals","volume":"32","author":"Lambert","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0969-8043(99)00093-7","article-title":"Preparation and biodistribution of rhenium-188 labeled albumin microspheres B 20: a promising new agent for radiotherapy","volume":"52","author":"Wunderlich","year":"2000","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib14","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.apradiso.2005.01.001","article-title":"A kit labeling of [188Re] human serum albumin microspheres for therapeutic use in nuclear medicine","volume":"62","author":"Wunderlich","year":"2005","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.apradiso.2004.11.003","article-title":"Labeling and biodistribution of different particle materials for radioembolization therapy with 188Re","volume":"62","author":"Wunderlich","year":"2005","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib16","first-page":"428","article-title":"Gallium-68 labeling of albumin and albumin microspheres","volume":"20","author":"Wagner","year":"1979","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib17","first-page":"623","article-title":"Albumin microspheres labeled with Ga-67 by chelation: concise communication","volume":"22","author":"Hnatowich","year":"1981","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.nucmedbio.2003.08.004","article-title":"Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice","volume":"31","author":"Lewis","year":"2004","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/bc0502356","article-title":"Radiolanthanide-labeled monoclonal antibody CC49 for radioimmunotherapy of cancer: biological comparison of DOTA conjugates and 149Pm, 166Ho, and 177Lu","volume":"17","author":"Mohsin","year":"2006","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2007.10.008_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ddr.10157","article-title":"Biopolymer albumin for diagnosis and drug delivery","volume":"58","author":"Patil","year":"2003","journal-title":"Drug Dev Res"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805107002715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805107002715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T08:13:30Z","timestamp":1684138410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805107002715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0969805107002715"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2007.10.008","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}